Merck KGaA ١ مايو ٢٠٢٦ Merck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.st
Merck KGaA ١ مايو ٢٠٢٦ Merck KGaA doses first patient in Phase III programme of enpatoran - Clinical Trials Arena
Merck KGaA ٢٨ أبريل ٢٠٢٦ Remepy, Merck KGaA pair up to test app-paired drug model in rare tumour - FirstWord Pharma
Merck KGaA ٢٨ أبريل ٢٠٢٦ Merck KGaA and Remepy join forces to develop combo drug-digital therapies - Medical Device Network
Merck KGaA ٢٧ أبريل ٢٠٢٦ Merck KGaA: Small Breakout In 2026, Followed By Normalization (OTCMKTS:MKGAF) - Seeking Alpha
FierceBiotech ٢٢ أبريل ٢٠٢٦ Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
FierceBiotech ٢١ أبريل ٢٠٢٦ In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
BioPharma Dive ٢٠ أبريل ٢٠٢٦ AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle
FierceBiotech ١٧ أبريل ٢٠٢٦ Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
Endpoints News ٨ أبريل ٢٠٢٦ Merck adjusts its vaccine supply deal in China; Soleno withdraws EU application
Endpoints News ٧ أبريل ٢٠٢٦ Terns sold to Merck for 13% lower than pharma's initial offer because of clinical data